Diagnostik einer endokrinen Hypertonie: Wann screenen, und mit welchem Test?

Schlüsselwörter

Hypertonie

Keywords

hypertension

Literatur

• 1 Baguet J P. et al . Circumstances of discovery of phaeochromocytoma: a retrospective study of 41 consecutive patients.  Eur J Endocrinol. 2004;  150 681-686
• 2 Beuschlein F, Reincke M. [Therapy-resistant hypertension – the endocrinological view].  MMW Fortschr Med. 2007;  149 29-32
• 3 Born-Frontsberg E, Quinkler M. [Conn’s syndrome].  Internist. 2009;  50 17-26
• 4 Dodt C. et al . [Glucocorticoids and hypertension].  Internist. 2009;  50 36-41
• 5 Findling J W, Raff H. Screening and diagnosis of Cushing’s syndrome.  Endocrinol Metab Clin North Am. 2005;  34 385-402
• 6 Funder J W. et al . Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline.  J Clin Endocrinol Metab. 2008;  93 3266-3281
• 7 Hannemann A. The increased aldosterone-to-renin ratio in North and South Germany: Results from SHIP and KORA.  Dtsch Med Wochenschr. 2010;  135 (Suppl. 4) 148 (Abstract)
• 8 Karagiannis A. et al . Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism.  Expert Opin Pharmacother. 2008;  9 509-515
• 9 Kearney P M. et al . Global burden of hypertension: analysis of worldwide data.  Lancet. 2005;  365 217-223
• 10 Lenders J W. et al . Biochemical diagnosis of pheochromocytoma: which test is best?.  J Am Med Assoc. 2002;  287 1427-1434
• 11 Mulatero P. et al . Evaluation of primary aldosteronism.  Curr Opin Endocrinol Diabetes Obes. 2010;  17 188-193
• 12 Nieman L K. et al . The diagnosis of Cushing’s syndrome: an Endocrine Society Clinical Practice Guideline.  J Clin Endocrinol Metab. 2008;  93 1526-1540
• 13 Reisch N. et al . [Pheochromocytoma – still a challenge].  Internist. 2009;  50 27-35
• 14 Rossi G P. et al . A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.  J Am Coll Cardiol. 2006;  48 2293-300
• 15 Rossi G P, Seccia T M, Pessina A C. Clinical use of laboratory tests for the identification of secondary forms of arterial hypertension.  Crit Rev Clin Lab Sci. 2007;  44 1-85
• 16 Tomaschitz A, Pilz S. Aldosterone to renin ratio – a reliable screening tool for primary aldosteronism?.  Horm Metab Res. 2010;  42 382-391
• 17 Viardot A. et al . Reproducibility of nighttime salivary cortisol and its use in the diagnosis of hypercortisolism compared with urinary free cortisol and overnight dexamethasone suppression test.  J Clin Endocrinol Metab. 2005;  90 5730-5736
• 18 Yeo H, Roman S. Pheochromocytoma and functional paraganglioma.  Curr Opin Oncol. 2005;  17 13-18
• 19 Young W F. Primary aldosteronism: renaissance of a syndrome.  Clin Endocrinol (Oxf). 2007;  66 607-618
• 20 Montori V M, Young jr W F. Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism.   Endocrinol Metab Clin North Am . 2002;  31 619-632